---
figid: PMC2789858__nihms-150768-f0006
figlink: /pmc/articles/PMC2789858/figure/F6/
number: F6
caption: Schematic model showing the role of physiological synaptic vs. excessive
  extrasynaptic NMDAR activity in the neurodegeneration of Huntington’s disease. Physiological
  synaptic NMDAR activity promotes neuroprotection, in part by facilitating non-toxic
  aggregation of mtHtt via the chaperonin TRiC. Otherwise toxic mtHtt would interfere
  with the neuroprotective CREB-PGC-1α pathway. In contrast, extrasynaptic NMDAR activity
  promotes neuronal cell injury and death, in part by increasing the relative level
  of Rhes, and, in conjunction with soluble/toxic mtHtt, by contributing to transcriptional
  deregulation of the CREB-PGC-1α cascade. Drugs inhibiting extrasynaptic or synaptic
  activity are indicated. Note that most NMDAR antagonists, as well as high concentrations
  of memantine, block both synaptic and extrasynaptic NMDAR-mediated currents, while
  low concentrations of memantine block predominantly the extrasynaptic component,
  thus relatively sparing synaptic activity and promoting neuroprotection.
pmcid: PMC2789858
papertitle: Balance between synaptic versus extrasynaptic NMDA receptor activity influences
  inclusions and neurotoxicity of mutant huntingtin.
reftext: Shu-ichi Okamoto, et al. Nat Med. 2009 Dec;15(12):1407-1413.
pmc_ranked_result_index: '131539'
pathway_score: 0.8984354
filename: nihms-150768-f0006.jpg
figtitle: Schematic model showing the role of physiological synaptic vs
year: '2009'
organisms:
- Homo sapiens
ndex: 61ece652-de95-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2789858__nihms-150768-f0006.html
  '@type': Dataset
  description: Schematic model showing the role of physiological synaptic vs. excessive
    extrasynaptic NMDAR activity in the neurodegeneration of Huntington’s disease.
    Physiological synaptic NMDAR activity promotes neuroprotection, in part by facilitating
    non-toxic aggregation of mtHtt via the chaperonin TRiC. Otherwise toxic mtHtt
    would interfere with the neuroprotective CREB-PGC-1α pathway. In contrast, extrasynaptic
    NMDAR activity promotes neuronal cell injury and death, in part by increasing
    the relative level of Rhes, and, in conjunction with soluble/toxic mtHtt, by contributing
    to transcriptional deregulation of the CREB-PGC-1α cascade. Drugs inhibiting extrasynaptic
    or synaptic activity are indicated. Note that most NMDAR antagonists, as well
    as high concentrations of memantine, block both synaptic and extrasynaptic NMDAR-mediated
    currents, while low concentrations of memantine block predominantly the extrasynaptic
    component, thus relatively sparing synaptic activity and promoting neuroprotection.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PPARGC1A
  - GRIN2B
  - MARVELD2
  - RASD2
  - GRIN2D
  - CREM
  - CREB3L4
  - CREB1
  - GRIN2C
  - ATF1
  - CREB3
  - ATF2
  - GRIN1
  - GRIN2A
  - OPN1LW
  - CREB5
  - GRIN3A
  - GRIN3B
  - CREB3L2
  - CREB3L1
  - CREB3L3
  - NO-711
  - Memantine
genes:
- word: PGC-1a
  symbol: PGC-1alpha
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: TRIC
  symbol: TRIC
  source: hgnc_alias_symbol
  hgnc_symbol: MARVELD2
  entrez: '153562'
- word: Rhes
  symbol: Rhes
  source: hgnc_alias_symbol
  hgnc_symbol: RASD2
  entrez: '23551'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: CBP
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
chemicals:
- word: NO-711
  source: MESH
  identifier: C078793
- word: Memantine
  source: MESH
  identifier: D008559
diseases: []
figid_alias: PMC2789858__F6
redirect_from: /figures/PMC2789858__F6
figtype: Figure
---
